Quest Diagnostics Inventory 2010-2024 | DGX

Quest Diagnostics inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • Quest Diagnostics inventory for the quarter ending September 30, 2024 was $0.184B, a 0% increase year-over-year.
  • Quest Diagnostics inventory for 2023 was $0.19B, a 1.04% decline from 2022.
  • Quest Diagnostics inventory for 2022 was $0.192B, a 7.69% decline from 2021.
  • Quest Diagnostics inventory for 2021 was $0.208B, a 6.73% decline from 2020.
Quest Diagnostics Annual Inventory
(Millions of US $)
2023 $190
2022 $192
2021 $208
2020 $223
2019 $123
2018 $99
2017 $95
2016 $82
2015 $84
2014 $110
2013 $91
2012 $93
2011 $89
2010 $77
2009 $91
Quest Diagnostics Quarterly Inventory
(Millions of US $)
2024-09-30 $184
2024-06-30 $182
2024-03-31 $181
2023-12-31 $190
2023-09-30 $184
2023-06-30 $184
2023-03-31 $190
2022-12-31 $192
2022-09-30 $183
2022-06-30 $187
2022-03-31 $197
2021-12-31 $208
2021-09-30 $205
2021-06-30 $199
2021-03-31 $223
2020-12-31 $223
2020-09-30 $205
2020-06-30 $154
2020-03-31 $126
2019-12-31 $123
2019-09-30 $112
2019-06-30 $105
2019-03-31 $98
2018-12-31 $99
2018-09-30 $95
2018-06-30 $91
2018-03-31 $94
2017-12-31 $95
2017-09-30 $100
2017-06-30 $83
2017-03-31 $77
2016-12-31 $82
2016-09-30 $82
2016-06-30 $80
2016-03-31 $82
2015-12-31 $84
2015-09-30 $86
2015-06-30 $109
2015-03-31 $106
2014-12-31 $110
2014-09-30 $111
2014-06-30 $109
2014-03-31 $99
2013-12-31 $91
2013-09-30 $85
2013-06-30 $89
2013-03-31 $90
2012-12-31 $93
2012-09-30 $95
2012-06-30 $90
2012-03-31 $88
2011-12-31 $89
2011-09-30 $85
2011-06-30 $88
2011-03-31 $72
2010-12-31 $77
2010-09-30 $73
2010-06-30 $78
2010-03-31 $79
2009-12-31 $91
2009-09-30 $81
2009-06-30 $80
2009-03-31 $87
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.788B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00